Obe K.L. Tsun

Learn More
1 Screening Population 2 Runing title: Evaluation of GenoFlow HPV Test 3 4 Oscar Gee-Wan Wong, C.K. Lo, Joanne N.K. Chow, Obe K.L. Tsun, Elaine 5 Szeto, Stephanie S. Liu, Hextan Y.S. Ngan, Annie N.Y. Cheung 6 7 Department of Pathology, and Obstetrics & Gynaecology, Queen Mary Hospital, 8 The University of Hong Kong, Hong Kong Special Administrative Region,(More)
High-risk human papillomavirus (HR-HPV) DNA detection in cervical cytology samples is useful for primary screening of cervical cancer and for triage of patients with equivocal cytological findings. The GenoFlow HPV array test (GF assay; Diagcor Bioscience Inc., Hong Kong) was recently developed to detect 33 HPV genotypes by a "flowthrough" hybridization(More)
OBJECTIVES To compare the PathVysion fluorescence in-situ hybridisation assay with the INFORM HER2 Dual in-situ hybridisation assay on 104 invasive breast cancers with a broad spectrum of immunohistochemistry scores. METHODS This case series involved consecutive patients diagnosed with invasive breast carcinoma with equivocal immunohistochemistry score(More)
BACKGROUND The current study reports on the significance of cervical smears identified as atypical squamous cells of undetermined significance (ASCUS) in the largest Asian screening population to date. METHODS From January 1998 to December 1999, 190,000 cervical smears were evaluated by the cervical cytology laboratory at the University of Hong Kong (Hong(More)
  • 1